The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.

CTAM Fund Impact: Edwin Kan

March 6, 2019

Edwin Kan

Near-field coherent sensing (NCS) demonstration in an automotive seat.

Edwin Kan and his team developed a non-invasive, low-cost method to monitor human and animal vital signs using passive and active radio frequency (RF) transmissions. Using near-field coherent sensing (NCS), researchers are able to measure internal body movement, such as a beating heart, in a precise, non-invasive method. This technology could be used in a broad variety of applications, but sometimes innovations need to be refined down into very specific applications before they can showcase their value in a particular industry.


“My group under the university research receives federal funding mostly to demonstrate innovative concepts that are broadly applicable, where specific product development is excluded,” said Kan.


As a 2018 Cornell Technology Acceleration and Maturation (CTAM) Fund recipient for a project titled “Accurate and reliable scoring of alertness and sleep states in seats and beds,” Kan was able to build specific prototypes and perform realistic demonstrations. The group assembled an automotive seat utilizing the NCS sensors that could retrieve the driver’s cardiopulmonary waveforms to determine alertness. They also integrated a sensor into a mattress to measure sleep study scoring.


“Most of the automotive and biomedical equipment companies are only willing to assign resources for product development after conceptual research has shown initial testing under their application scenarios,” said Kan. “CTAM funding bridges that gap not only to increase the interest of technology licensing in those industry sectors, but also to boost patent strength and value of the IP.”


The Cornell Technology Acceleration and Maturation (CTAM) Fund was implemented to give Cornell technologies that might be considered “too early” for a commercialization partnership an opportunity to further develop the technology. CTAM’s objective is to address the “invest-ability” gaps and “license-ability” that deter signification investment, strategic partnership, or acquisition. For each CTAM project, the fund provides up to a $50,000 investment that can be used for activities such as prototype development, beta-testing, data analysis, market research, and business plan refinement. (Note: CTAM has now developed into the IGNITE Cornell Research Gap Funding Program.)


Without the assistance of CTAM funding, Edwin Kan and his group wouldn’t have been able to build these specific prototypes, perform realistic demonstrations, and collect initial evaluation information.


Kan and his team have plans to further refine NCS demonstration kits on small PCB boards, ideally working with a large electronic hardware company with strong integrated circuit experience.